image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Cake Box Like-for-like sales accelerate

October 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CBOX
  • Price:
  • 160p
In an encouraging update Cake Box said sales grew 6.8% in the first 17 weeks to 30th July, marking an acceleration on the 5.4% increase seen in the first 11 weeks. At the same time input costs have fallen, most notably fresh cream (down 25% year-on-year) with European and UK dairy prices easing. Seven franchise stores have been added in the period taking the total to 212 versus its upwardly revised target of 400. With the company increasing its investment in brand awareness a pleasing milestone was the new website launch in June; in FY’23 online represented just over 20% franchisee sales. After payment of the 5.5p final dividend, Cake Box had cash of £6.7m. Shore Cap has left forecasts unchanged for £5.8m pretax prof ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author